Cadrenal Therapeutics, Inc. (CVKD) › EPS (Diluted)Cadrenal Therapeutics, Inc. (CVKD) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2023: $-9.292024: $-8.732025: $-6.64$-6.642023EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-6.64+23.9%2024$-8.73+6.0%2023$-9.29—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share